• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性高血压患者的心房利钠肽。血流动力学、肾脏及激素反应。

Atrial natriuretic peptide in patients with essential hypertension. Hemodynamic, renal, and hormonal responses.

作者信息

Predel H G, Schulte-Vels O, Glänzer K, Meyer-Lehnert H, Kramer H J

机构信息

Medizinische Poliklinik, University of Bonn, Germany.

出版信息

Am J Hypertens. 1991 Nov;4(11):871-9. doi: 10.1093/ajh/4.11.871.

DOI:10.1093/ajh/4.11.871
PMID:1665067
Abstract

In six patients with essential hypertension (EH) and in six healthy volunteers (C) the effects of a 60-min intravenous (iv) infusion of human atrial natriuretic peptide (alpha-hANP) (24 ng/min/kg) on systemic and renal hemodynamics and renal excretory function were evaluated. Basal plasma ANP concentrations in patients with EH were higher (P less than .05) than in C (30.9 +/- 4.5 v14.0 +/- 1.7 pmol/L). Maximal effects of alpha-hANP infusion occurred after 30 to 60 min. Blood pressure (BP) declined from 154 +/- 5/109 +/- 4 to 139 +/- 7/94 +/- 4 in EH and from 117 +/- 1/72 +/- 2 to 106 +/- 1/65 +/- 3 mm Hg in C (P less than .05). Cardiac output (CO) increased transiently from 6.1 +/- 0.3 to 6.5 +/- 0.4 L/min in EH and from 6.8 +/- 0.3 to 7.2 +/- 0.5 L/min in C, whereas heart rate (HR) remained constant both in patients with EH and in C (69 +/- 3 to 72 +/- 5 and 60 +/- 3 to 63 +/- 3/min). The increases in urine flow and in urinary sodium excretion from 3.6 +/- 0.2 to 16.0 +/- 2.0 mL/min and from 230 +/- 33 to 1004 +/- 137 mumol/min, respectively, in EH were more pronounced than in C (from 3.9 +/- 1.0 to 8.4 +/- 0.8 mL/min and from 211 +/- 37 to 451 +/- 84 mumol/min); (P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对6例原发性高血压(EH)患者和6名健康志愿者(C),评估了静脉输注人心房利钠肽(α-hANP)(24 ng/min/kg)60分钟对全身及肾脏血流动力学和肾脏排泄功能的影响。EH患者的基础血浆ANP浓度高于C组(P<0.05)(30.9±4.5对14.0±1.7 pmol/L)。α-hANP输注的最大效应出现在30至60分钟后。EH组血压(BP)从154±5/109±4降至139±7/94±4,C组从117±1/72±2降至106±1/65±3 mmHg(P<0.05)。EH组心输出量(CO)从6.1±0.3短暂增加至6.5±0.4 L/min,C组从6.8±0.3增加至7.2±0.5 L/min,而EH患者和C组的心率(HR)均保持恒定(69±3至72±5和60±3至63±3次/分钟)。EH组尿流量和尿钠排泄量分别从3.6±0.2增加至16.0±2.0 mL/min和从230±33增加至1004±137 μmol/min,比C组更显著(从3.9±1.0增加至8.4±0.8 mL/min和从211±37增加至451±84 μmol/min);(P<0.05)。(摘要截断于250字)

相似文献

1
Atrial natriuretic peptide in patients with essential hypertension. Hemodynamic, renal, and hormonal responses.原发性高血压患者的心房利钠肽。血流动力学、肾脏及激素反应。
Am J Hypertens. 1991 Nov;4(11):871-9. doi: 10.1093/ajh/4.11.871.
2
Intranasal application of atrial natriuretic peptide and 1-deamino-d-arginine vasopressin in healthy volunteers. Hemodynamic, hormonal, and renal excretory effects.心房利钠肽和1-去氨基-D-精氨酸血管加压素经鼻应用于健康志愿者。血流动力学、激素及肾脏排泄效应。
Am J Hypertens. 1992 Sep;5(9):657-60. doi: 10.1093/ajh/5.9.657.
3
[The significance of atrial natriuretic polypeptide in the cause of essential hypertension].[心房利钠多肽在原发性高血压病因中的意义]
Nihon Naibunpi Gakkai Zasshi. 1991 Jul 20;67(7):796-810. doi: 10.1507/endocrine1927.67.7_796.
4
Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.在原发性高血压中,对低剂量心房利钠肽输注的压力依赖性利钠反应增强。
J Intern Med. 1994 Dec;236(6):665-74. doi: 10.1111/j.1365-2796.1994.tb00860.x.
5
[The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].[急性给予心房利钠肽对原发性高血压患者利尿和利钠调节机制的影响]
Ann Ital Med Int. 1991 Jul-Sep;6(3):273-83.
6
Atrial natriuretic peptide in patients with diabetes mellitus type I. Effects on systemic and renal hemodynamics and renal excretory function.1型糖尿病患者的心房利钠肽。对全身和肾脏血流动力学及肾脏排泄功能的影响。
Am J Hypertens. 1990 Sep;3(9):674-81. doi: 10.1093/ajh/3.9.674.
7
Renal effects of atrial natriuretic peptide during dopamine infusion.
Am J Hypertens. 1990 Nov;3(11):866-9. doi: 10.1093/ajh/3.11.866.
8
Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure.心房利钠肽对慢性肾衰竭患者全身和肾脏血流动力学及肾脏排泄功能的影响。
Klin Wochenschr. 1991 Nov 26;69(19):895-903. doi: 10.1007/BF01649565.
9
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.低剂量心房利钠肽在代偿期肝硬化中的心血管和肾脏效应
Am J Gastroenterol. 1997 May;92(5):852-7.
10
Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.正常人静注人心房利钠肽4小时的血流动力学、肾脏及内分泌效应
Fundam Clin Pharmacol. 1988;2(5):413-29. doi: 10.1111/j.1472-8206.1988.tb01007.x.

引用本文的文献

1
Natriuretic Peptides as a Novel Target in Resistant Hypertension.利钠肽作为难治性高血压的新靶点
Curr Hypertens Rep. 2015 Mar;17(3):18. doi: 10.1007/s11906-014-0530-0.
2
Regulatable atrial natriuretic peptide gene therapy for hypertension.用于高血压的可调节心房利钠肽基因治疗
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13789-94. doi: 10.1073/pnas.0506807102. Epub 2005 Sep 14.